L. Stein Gold, L. Kircik, E. Tanghetti, H. Baldwin, M. Gold, Z. Draelos, E. Lain, D. Pariser, N. Sadick, R. Pillai, V. Bhatt
{"title":"固定剂量1.2%克林霉素磷酸酯、3.1%过氧化苯甲酰和0.15%阿达帕林凝胶治疗中重度痤疮的疗效和安全性:第一种三联用药的随机2期和3期研究","authors":"L. Stein Gold, L. Kircik, E. Tanghetti, H. Baldwin, M. Gold, Z. Draelos, E. Lain, D. Pariser, N. Sadick, R. Pillai, V. Bhatt","doi":"10.25251/skin.7.supp.159","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":74803,"journal":{"name":"Skin (Milwood, N.Y.)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Randomized Phase 2 and Phase 3 Studies of the First Triple-Combination Drug\",\"authors\":\"L. Stein Gold, L. Kircik, E. Tanghetti, H. Baldwin, M. Gold, Z. Draelos, E. Lain, D. Pariser, N. Sadick, R. Pillai, V. Bhatt\",\"doi\":\"10.25251/skin.7.supp.159\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":74803,\"journal\":{\"name\":\"Skin (Milwood, N.Y.)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Skin (Milwood, N.Y.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25251/skin.7.supp.159\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Skin (Milwood, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25251/skin.7.supp.159","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Randomized Phase 2 and Phase 3 Studies of the First Triple-Combination Drug